New nurse-led protocols for stroke patients, based on ACU research, led by the Nursing Research Institute, have resulted in changes to policy, guidelines and clinical practice in Europe and Australia. The protocols were developed through the Quality in Acute Stroke Care (QASC) Trial (published in the Lancet, 2011) to manage fever, hyperglycaemia and swallowing (FeSS) post-stroke.
Professor Sandy Middleton FACN, FAAN is a Professor of Nursing and Director of the Nursing Research Institute at St Vincent’s Health Network Sydney, St Vincent’s Hospital Melbourne and Australian Catholic University. She focusses on stroke and the way research can improve care, particularly analysing the way nurses can initiate care to improve patient recovery.
Professor Middleton was the lead investigator on the landmark NHMRC-funded QASC cluster trial that demonstrated decreased death and dependency following implementation of nurse-initiated protocols to manage fever, hyperglycaemia and swallowing post-stroke, winning multiple national and international awards including ACU’s Vice-Chancellor’s Staff Excellence Award, Excellence in Research and Research Partnerships in 2019. These protocols have been translated into 64 hospitals in 17 European countries and in adopted in 36 NSW hospitals. She has published in high impact journals including The Lancet and The New England Journal of Medicine.
Australian Health Journal spoke with Professor Sandy Middleton on these significant achievements in nurse-led acute stroke care.
You Might also like
-
Intersection of multiple births, birth trauma and perinatal mental health
Mothers of multiples are five times more likely to experience depression and have triple the rates of anxiety compared to mothers of singletons. Danya McStein is a Clinical Team Manager at Gidget Foundation Australia, talks about mothers expecting twins showing prenatal depressive symptoms, while postpartum, facing higher risks of clinical exhaustion and postpartum depression.
-
Value of MedTech Report brings Industry and Government together
In June 2023 the Medical Technology Association of Australia (MTAA) launched The Value of MedTech Report – a major study quantifying the difference the MedTech industry makes to the lives of Australian patients, the healthcare system and the Australian economy.
Australian Health Journal spoke with MTAA CEO, Ian Burgess and MTAA Policy Manager, Pravin Siriwardena about the report and its key findings.
-
Connected Health Systems
Challenges in health care delivery have compounded, with clinical staff being exposed to the Omicron COVID variant. Reduced staffing has brought on its challenges to most already-strained state health care systems and the people working in them.
However, over the past 2 years of the pandemic, technology has played an increasing role on the front end for patients and consumers at home and clinicians in the medical setting. Much more is planned in technology that will deliver efficiency, reduce risk and make available new models of care. This has the potential to touch the working lives of all stakeholders and recipients of care.